PLA1A
Basic information
Region (hg38): 3:119597875-119629811
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PLA1A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 19 | 21 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 19 | 1 | 4 |
Variants in PLA1A
This is a list of pathogenic ClinVar variants found in the PLA1A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-119606791-C-A | not specified | Uncertain significance (Oct 12, 2021) | ||
3-119606863-C-T | not specified | Uncertain significance (Aug 13, 2021) | ||
3-119606941-A-G | not specified | Uncertain significance (Jan 23, 2024) | ||
3-119608801-A-G | not specified | Uncertain significance (Sep 02, 2024) | ||
3-119608829-C-T | not specified | Uncertain significance (Mar 12, 2024) | ||
3-119608865-G-A | not specified | Uncertain significance (Dec 06, 2022) | ||
3-119608937-A-G | not specified | Likely benign (Dec 20, 2023) | ||
3-119609469-T-A | not specified | Uncertain significance (Mar 25, 2024) | ||
3-119613040-T-C | not specified | Uncertain significance (May 10, 2024) | ||
3-119613065-G-A | not specified | Uncertain significance (Jan 09, 2024) | ||
3-119616021-T-G | not specified | Uncertain significance (Jun 29, 2023) | ||
3-119616032-G-A | not specified | Uncertain significance (Aug 13, 2021) | ||
3-119616047-T-C | not specified | Uncertain significance (Oct 10, 2023) | ||
3-119618049-G-A | not specified | Uncertain significance (Mar 21, 2022) | ||
3-119618071-C-G | not specified | Uncertain significance (Jan 26, 2023) | ||
3-119618071-C-T | Benign (Mar 29, 2018) | |||
3-119618133-C-A | not specified | Uncertain significance (Dec 03, 2024) | ||
3-119619597-G-A | Benign (Mar 29, 2018) | |||
3-119619622-C-A | not specified | Uncertain significance (Sep 22, 2023) | ||
3-119625183-G-A | EBV-positive nodal T- and NK-cell lymphoma | Likely benign (-) | ||
3-119628713-A-G | Benign (Mar 29, 2018) | |||
3-119628721-G-A | not specified | Uncertain significance (Apr 09, 2024) | ||
3-119628778-A-T | not specified | Uncertain significance (Oct 28, 2024) | ||
3-119628796-G-A | not specified | Uncertain significance (Dec 17, 2023) | ||
3-119628844-C-T | not specified | Uncertain significance (Oct 18, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PLA1A | protein_coding | protein_coding | ENST00000273371 | 11 | 31970 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.37e-11 | 0.190 | 125691 | 0 | 57 | 125748 | 0.000227 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.286 | 244 | 257 | 0.950 | 0.0000139 | 2970 |
Missense in Polyphen | 87 | 88.237 | 0.98598 | 1036 | ||
Synonymous | -0.234 | 100 | 97.1 | 1.03 | 0.00000548 | 887 |
Loss of Function | 0.714 | 18 | 21.6 | 0.834 | 0.00000100 | 254 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000868 | 0.000868 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000264 | 0.000264 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Hydrolyzes the ester bond at the sn-1 position of glycerophospholipids and produces 2-acyl lysophospholipids. Hydrolyzes phosphatidylserine (PS) in the form of liposomes and 1- acyl-2 lysophosphatidylserine (lyso-PS), but not triolein, phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidic acid (PA) or phosphatidylinositol (PI). Isoform 2 hydrolyzes lyso-PS but not PS. Hydrolysis of lyso-PS in peritoneal mast cells activated by receptors for IgE leads to stimulate histamine production. {ECO:0000269|PubMed:10196188}.;
- Pathway
- Ras signaling pathway - Homo sapiens (human);Ras Signaling;Metabolism of lipids;Metabolism;Acyl chain remodelling of PS;Glycerophospholipid biosynthesis;Phospholipid metabolism
(Consensus)
Recessive Scores
- pRec
- 0.157
Intolerance Scores
- loftool
- 0.212
- rvis_EVS
- 0.89
- rvis_percentile_EVS
- 89.24
Haploinsufficiency Scores
- pHI
- 0.0835
- hipred
- N
- hipred_score
- 0.199
- ghis
- 0.406
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.943
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pla1a
- Phenotype
Gene ontology
- Biological process
- lipid metabolic process;phosphatidylserine metabolic process;lipid catabolic process;phosphatidylserine acyl-chain remodeling
- Cellular component
- acrosomal membrane;extracellular region
- Molecular function
- phospholipase A1 activity;phosphatidylserine 1-acylhydrolase activity